Kestra director sells 15,000 shares at $20.04
Kestra Medical Technologies director and officer Brian Daniel Webster reported an open-market sale of 15,000 common shares on April 15, 2026 at a weighted average price of $20.0447 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kestra Medical Technologies director and officer Brian Daniel Webster reported an open-market sale of 15,000 common shares on April 15, 2026 at a weighted average price of $20.0447 per share. The trade was executed under a Rule 10b5-1 trading plan adopted on September 29, 2025, and Webster now holds 349,786 common shares directly.
Insider Trade Summary 10b5-1
Net Seller: 15,000 shares
Net Sell
1 txn
Insider
Webster Brian Daniel
Role
See Remarks
Sold
15,000 shs ($301K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 15,000 | $20.0447 | $301K |
Holdings After Transaction:
Common Shares — 349,786 shares (Direct)
Footnotes (2)
- F1. The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- F2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.2200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Key Figures
Shares sold: 15,000 shares
Weighted average sale price: $20.0447 per share
Post-transaction holdings: 349,786 shares
+2 more
5 metrics
Shares sold
15,000 shares
Open-market sale on April 15, 2026
Weighted average sale price
$20.0447 per share
Common shares sold in multiple trades
Post-transaction holdings
349,786 shares
Common shares held directly after sale
Price range
$20.0000–$20.2200 per share
Range of execution prices for reported sales
Rule 10b5-1 plan adoption date
September 29, 2025
Plan governing the reported sale
Key Terms
Rule 10b5-1 trading plan, weighted average price, open-market sale, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KMTS director Brian Daniel Webster report?
Brian Daniel Webster reported selling 15,000 KMTS common shares in an open-market transaction. The sale occurred at a weighted average price of $20.0447 per share, and was disclosed as a routine Form 4 insider transaction to the SEC.
Was the KMTS insider sale made under a Rule 10b5-1 trading plan?
Yes, the KMTS insider sale was made under a Rule 10b5-1 trading plan. The filing states the transaction occurred pursuant to a plan that Brian Daniel Webster adopted on September 29, 2025, indicating it was a pre-arranged, scheduled trading program.
What does the weighted average sale price mean in the KMTS Form 4 filing?
The weighted average price of $20.0447 represents the average price across multiple trade executions. The filing notes that individual sale prices ranged from $20.0000 to $20.2200, and the exact number of shares sold at each price is available upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
